Trial Profile

Randomized, double-blind, placebo-controlled exploratory Phase 2A clinical study of PH80 for the acute management of menopausal hot flashes in women

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 08 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PH 80 (Primary)
Indications Hot flashes
Focus Adverse reactions; Therapeutic Use

Most Recent Events

05 Nov 2024 According to a VistaGen media release, data from the study will be presented at the 2024 Neuroscience Education Institute (NEI) Congress in Colorado Springs, Colorado from November 7 to 10, 2024.
07 Nov 2023 According to a Vistagen media release, data from this trial will be presented at the 2023 Neuroscience Education Institute (NEI) Congress.
14 Jun 2023 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com